Orderable LOINC Terms Value set¶
| Canonical | https://fhir.apps.health/ValueSet/nexus-loinc-orderable |
|---|---|
| Status | draft · 1.33.0 |
| Source | FSH · JSON |
Every LOINC term that can be ordered: the terms whose ORDER_OBS property is Order or Both,
excluding the LOINC Document Ontology and deprecated terms. Order terms are orderable only (a panel ordered as a unit); Both terms
may be ordered or reported. Terms that are Observation only, Subset, or that carry no ORDER_OBS
value are not members. Most Document Ontology terms are Both, and they are excluded so that a
document kind is never offered as a test (they are matched by CLASS = LP32519-8, the Part for
the Document Ontology class).
Defined, not enumerated. The set is a filter on LOINC's own properties, so its membership follows
the LOINC release the terminology service holds and needs no release of this guide. It carries no
expansion; $expand it against the terminology service.
Clinical documents are a separate set, and it is LOINC's. A field that takes either an orderable
test or a document kind offers this set and
http://loinc.org/vs/loinc-document-ontology, the
LOINC Document Ontology, as alternatives. This guide defines no document set of its own.
Definition¶
Includes
- Codes from LOINC where
ORDER_OBSisOrderorBoth
Excludes
Codes¶
This set has 56,840 codes, as the terminology service expands it. 500 are shown below, spread evenly across the code range; this page is not the expansion.
Displays from version 2.83.
The sample is drawn from the 56,275 of them that may be reproduced here; 565 carrying a third-party copyright notice are counted but not shown.
Attribution required by the publisher
This material contains content from LOINC (https://loinc.org). LOINC is copyright (c) 1995+ Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the LOINC licence (https://loinc.org/license). LOINC(R) is a registered United States trademark of Regenstrief Institute, Inc. Terms carrying a third-party copyright notice are not reproduced here.
| Code | Display |
|---|---|
1-8 |
Acyclovir [Susceptibility] |
100388-8 |
Cocoa IgG Ab [Units/volume] in Serum |
100749-1 |
Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |
100894-5 |
Recommended screening frequency Narrative |
101175-8 |
3-Methoxytyramine.free/Creatinine [Molar ratio] in Serum or Plasma |
101364-8 |
Francisella tularensis DNA [Presence] in Blood by NAA with non-probe detection |
101521-3 |
Hemorrhagic enteritis virus Ab/Positive control in Serum by Immunoassay |
101697-1 |
Post traumatic stress disorder checklist - civilian version DSM-5 [PCL-5] |
101858-9 |
Triamcinolone acetonide [Moles/volume] in Urine |
102020-5 |
Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucagon |
103179-8 |
Haemophilus ducreyi DNA [Presence] in Urine by NAA with probe detection |
103310-9 |
XR Spine Lumbar and Sacrum Single view |
103415-6 |
Portable XR Wrist - left 2 Views |
103519-5 |
XR Wrist - right 1 or 2 Views |
103651-6 |
Atomoxetine [Presence] in Urine by Confirmatory method |
103850-4 |
RF Kidney Views W contrast via nephrostomy tube |
104062-5 |
HISGT Histone genes targeted mutation analysis in Tumor by Molecular genetics method |
104248-0 |
Pepsinogen I/Pepsinogen II [Mass Ratio] in Serum |
104369-4 |
Clostridium baratii [Presence] in Specimen |
104541-8 |
Clonazepam and 7-aminoclonazepam panel - Serum |
10476-0 |
Desmin Ag [Presence] in Tissue by Immune stain |
105025-1 |
Bacterial Carbapenem resistance blaOXA 181 gene [Presence] by Molecular method |
105144-0 |
MRA Head vessels and Neck vessels W contrast IV |
10531-2 |
Bretylium [Mass/volume] in Serum or Plasma |
105598-7 |
SDHA and SDHB and SDHC and SDHD targeted gene mutation analysis in Tissue by Molecular genetics method |
106111-8 |
Sperm head [Description] in Semen |
106336-1 |
US Hand - left |
106584-6 |
Candida glabrata DNA [Presence] in Body fluid by NAA with non-probe detection |
106818-8 |
RF Guidance of Lower extremity - right |
106972-3 |
Chlorodehydromethyltestosterone [Presence] in Urine by Gas chromatography-mass spectrometry |
107138-0 |
General structured lab report |
10728-4 |
Trichomonas sp identified in Genital specimen by Organism specific culture |
107448-3 |
Duchenne muscular dystrophy newborn screen interpretation newborn screen interpretation |
107581-1 |
Respiratory syncytial virus genome [Nucleotide sequence] in Isolate or Specimen by Sequencing |
107735-3 |
Raisin IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
107849-2 |
Chicken IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
108004-3 |
6-Monoacetylmorphine (6-MAM) [Measurement] in Urine |
108129-8 |
Curry IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
108264-3 |
MDS v3.0 - RAI v1.20.1 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] |
108433-4 |
Benztropine [Measurement] in Urine |
108573-7 |
16-Alpha hydroxypregnenolone [Measurement] in Urine |
108707-1 |
Ethchlorvynol [Measurement] in Serum or Plasma |
108831-9 |
Lysergate diethylamide [Measurement] in Serum or Plasma |
10897-7 |
Eastern equine encephalitis virus IgG Ab [Titer] in Cerebrospinal Fluid by Immunofluorescence |
109111-5 |
Wuchereria bancrofti Ab [Measurement] in Serum |
109271-7 |
Aspergillus terreus Ab [Measurement] in Serum |
109411-9 |
HIV 1 Ab [Measurement] in Body fluid |
109560-3 |
7-Dehydrocholesterol [Measurement] in Amniotic fluid |
10970-2 |
Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood |
109817-7 |
HTLV I+II Ab [Measurement] in Cerebrospinal Fluid |
109937-3 |
Francisella tularensis IgG Ab [Measurement] in Serum |
110042-9 |
Candida sp Ag [Measurement] in Serum |
110151-8 |
Schistosoma mansoni Ab [Measurement] in Serum |
110260-7 |
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Measurement] in Serum or Plasma |
110382-9 |
Methanol [Measurement] in Urine |
110535-2 |
Collagen crosslinked N-telopeptide/Creatinine [Measurement] in Urine |
110651-7 |
Flurazepam [Measurement] in Serum or Plasma |
110756-4 |
Sjogrens syndrome-B extractable nuclear IgG Ab [Measurement] in Serum |
110867-9 |
Aspergillus sp Ab [Measurement] in Cerebrospinal Fluid |
110974-3 |
Lassa virus IgM Ab [Measurement] in Serum |
111097-2 |
Sodium/Creatinine [Measurement] in Urine |
111279-6 |
Purkinje cells Ab [Measurement] in Serum |
111392-7 |
Iron [Measurement] in Urine |
111514-6 |
Microscopic observation [Identifier] in Fistula by Gram stain |
111634-2 |
Right eye Index Normals Flag Static Automated Perimetry |
111744-9 |
Breastfeeding assessment scale LATCH |
11236-7 |
Gemfibrozil [Mass/volume] in Serum or Plasma |
112744-8 |
Amphetamine [Presence] in Hair |
113006-1 |
Fungus identified in Drain by Culture |
113189-5 |
Zolpidem phenyl-4-carboxylate [Presence] in Urine by Immunoassay |
113305-7 |
Nordiazepam [Mass/mass] in Stool by Immunoassay |
113424-6 |
Delorazepam [Mass/volume] in Urine by Immunoassay |
113536-7 |
traMADol [Mass/volume] in Saliva (oral fluid) by Immunoassay |
113649-8 |
oxyMORphone [Mass/volume] in Serum, Plasma or Blood |
113761-1 |
Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Immunoassay |
113873-4 |
MDMB-4en-PINACA [Mass/volume] in Urine by Immunoassay |
113985-6 |
JWH-073 (synthetic cannabinoid) [Presence] in Urine by Mass Spectrometry |
114098-7 |
diazePAM [Mass/volume] in Serum or Plasma by Mass Spectrometry |
114210-8 |
6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Mass Spectrometry |
114323-9 |
Methadone+Metabolite [Presence] in Serum, Plasma or Blood |
114454-2 |
Norpropoxyphene [Presence] in Urine by Immunoassay |
114570-5 |
Tahyna virus RNA [Presence] in Specimen by Molgen |
114681-0 |
Rickettsia spotted fever group RNA [Presence] in Specimen by Molgen |
114784-2 |
Neisseria meningitidis serogroup C DNA [Presence] in Specimen by Molgen |
114890-7 |
Jamestown canyon virus RNA [Presence] in Specimen by Molgen |
115002-8 |
Histoplasma capsulatum rRNA [Presence] in Specimen by Molgen |
115113-3 |
Equine arteritis virus RNA [Presence] in Specimen by Molgen |
115217-2 |
Coccidioides sp DNA [Presence] in Specimen by Molgen |
115324-6 |
Brucella abortus rRNA [Presence] in Specimen by Molgen |
115435-0 |
Adenovirus RNA [Presence] in Specimen by Molgen |
11570-9 |
Platelet IgG Ab [Units/volume] in Serum |
12223-4 |
Human papilloma virus 16+18 Ag [Presence] in Genital specimen |
12367-9 |
Mesoridazine [Presence] in Urine |
1251-8 |
Major crossmatch [Interpretation] by Immediate spin |
12843-9 |
Protein [Mass/volume] in Peritoneal dialysis fluid |
13157-3 |
Streptococcus pneumoniae Danish serotype 18C Ab [Units/volume] in Serum --1st specimen |
13282-9 |
Rubella virus IgM Ab [Units/volume] in Cerebrospinal Fluid |
13556-6 |
Demoxepam [Presence] in Serum or Plasma |
13753-9 |
Hexanoylglycine/Creatinine [Mass Ratio] in Urine |
13952-7 |
Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
14125-9 |
Entamoeba histolytica [Presence] in Stool by Trichrome stain |
14267-9 |
Methylenedioxymethamphetamine [Presence] in Urine |
14427-9 |
Globulin [Mass/volume] in Pleural fluid |
14549-0 |
Mumps virus Ag [Presence] in Nose by Immunofluorescence |
14700-9 |
diphenhydrAMINE+dimenhyDRINATE [Presence] in Serum or Plasma |
14866-8 |
Parathyrin.intact [Moles/volume] in Serum or Plasma |
15036-7 |
Catecholamines [Moles/time] in 24 hour Urine |
15169-6 |
Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay |
15353-6 |
Apolipoprotein E4 [Presence] in Blood |
15495-5 |
PRRSV Ab [Presence] in Serum by Immunoassay |
16226-3 |
Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
16426-9 |
Babesia sp IgM Ab [Titer] in Serum |
1658-4 |
11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
16717-1 |
Cytomegalovirus Ag [Presence] in Urine by Immunoassay |
16863-3 |
Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunoassay |
17021-7 |
Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence |
1727-7 |
Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine |
17399-7 |
Human papilloma virus 16 Ag [Presence] in Specimen |
17531-5 |
Rh [Type] in Amniotic fluid |
17706-3 |
Thyroperoxidase Ab [Titer] in Cerebrospinal Fluid by Latex agglutination |
17867-3 |
Carnitine free (C0)/Creatinine [Ratio] in Urine |
18307-9 |
Ova and parasites identified in Stool by Iron hematoxylin stain |
1845-7 |
Ammonium ion [Moles/volume] in Plasma |
19058-7 |
Allergens identified in Serum |
19349-0 |
Aprobarbital [Presence] in Urine by Screen method |
19565-1 |
Methylenedioxyamphetamine [Presence] in Urine by Screen method |
19761-6 |
Thermoactinomyces vulgaris IgG Ab [Presence] in Serum |
20469-3 |
Acetone [Presence] in Serum or Plasma by Screen method |
20674-8 |
Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID) |
2078-4 |
Chloride [Moles/volume] in Urine |
20890-0 |
Monensin [Mass/mass] in Feed |
21018-7 |
CD61 cells [#/volume] in Blood |
2122-0 |
Chymopapain [Mass/volume] in Serum |
21466-8 |
Plasmodium malariae Ab [Titer] in Serum by Immunofluorescence |
21642-4 |
CACNA1S gene p.Arg1239Gly [Presence] in Blood or Tissue by Molecular genetics method |
2192-3 |
Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine |
22162-2 |
Candida albicans Ab [Presence] in Serum |
22268-7 |
Echovirus 11 Ab [Titer] in Serum |
22382-6 |
Legionella pneumophila 1 IgM Ab [Titer] in Serum |
22489-9 |
Rickettsia typhi IgG Ab [Titer] in Serum |
2266-5 |
Etiocholanolone [Presence] in Urine |
22822-1 |
Influenza virus A Ab [Presence] in Serum by Immunoassay |
22928-6 |
Brucella canis Ab [Presence] in Serum |
23039-1 |
Duck hepatitis virus 3 Ab [Presence] in Serum |
23144-9 |
Japanese encephalitis virus neutralizing antibody [Titer] in Serum by Neutralization test |
23250-4 |
Mycoplasma agalactiae Ab [Presence] in Serum by Immunoassay |
23361-9 |
Porcine enterovirus Ab [Presence] in Serum |
23470-8 |
Theileria mutans Ab [Presence] in Serum |
23584-6 |
Western equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
23732-1 |
Feline leukemia virus Ab [Presence] in Serum by Immunoassay |
23861-8 |
Ethanol [Mass/mass] in Tissue |
2404-2 |
Hemopexin [Mass/volume] in Urine |
24171-1 |
Polio virus 2 neutralizing antibody [Titer] in Serum by Neutralization test --1st specimen |
24294-1 |
Parainfluenza virus 2 Ab [Titer] in Serum --1st specimen |
24431-9 |
IgA.canine [Mass/volume] in Serum by Immune diffusion (ID) |
24580-3 |
RFA Guidance for angioplasty of Brachiocephalic artery-- W contrast IA |
2469-5 |
IgG subclass 4 [Mass/volume] in Serum |
24816-1 |
US Guidance for biopsy of Liver |
24926-8 |
US Spine |
25054-8 |
CT Guidance for radiosurgery of Unspecified body region-- W contrast IV |
25258-5 |
Itraconazole [Mass/volume] in Specimen |
25424-3 |
Trypanosoma sp Ab [Units/volume] in Serum by Immunofluorescence |
25682-6 |
Kappa light chains [Mass/time] in 24 hour Urine |
25954-9 |
Magnesium [Moles/volume] in 24 hour Urine |
26111-5 |
XR Elbow - right Views |
26224-6 |
CT Extremity - bilateral |
26331-9 |
RFA Guidance for change of CV catheter in Vein - bilateral-- W contrast IV |
2655-9 |
Neurotensin [Mass/volume] in Plasma |
26723-7 |
Varicella zoster virus Ab [Titer] in Cerebrospinal Fluid by Immunofluorescence |
26866-4 |
N-desalkylflurazepam [Mass/mass] in Meconium |
27000-9 |
Thyroxine (T4) [Mass/volume] in Saliva (oral fluid) |
27160-1 |
Hydrastine [Presence] in Serum or Plasma |
27284-9 |
Brompheniramine [Mass/volume] in Urine |
2747-4 |
pH of Cerebrospinal Fluid |
27999-2 |
Toxoplasma gondii DNA [Presence] in Amniotic fluid by NAA with probe detection |
28646-8 |
pH of Arterial cord blood |
29241-7 |
Mumps virus IgG Ab [Units/volume] in Body fluid |
29411-6 |
Nordoxepin [Mass/volume] in Gastric fluid |
29619-4 |
Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
29735-8 |
Leptospira interrogans sv Medanensis Ab [Presence] in Serum by Agglutination |
29850-5 |
Jamestown canyon virus IgM Ab [Presence] in Serum |
29977-6 |
Silver [Mass/volume] in 24 hour Urine |
30133-3 |
Coxsackievirus Ab [Presence] in Serum --2nd specimen |
30337-0 |
Echovirus 9 Ab [Presence] in Serum by Complement fixation |
30578-9 |
CT Guidance for drainage of abscess and placement of drainage catheter of Unspecified body region |
30687-8 |
MR Hip WO contrast |
30802-3 |
CT Maxillofacial region WO contrast |
30923-7 |
Chromium [Mass/volume] in Urine collected for unspecified duration |
31091-2 |
Gentamicin [Mass/volume] in Serum or Plasma --peak post extended interval dosing |
31242-1 |
Avian paramyxovirus 1 Ab [Units/volume] in Serum |
3135-1 |
Xylose [Mass/volume] in Urine |
31472-4 |
Legionella pneumophila IgM Ab [Units/volume] in Serum |
31587-9 |
Rhodococcus equi Ab [Presence] in Serum |
31726-3 |
Bacillus anthracis Ag [Presence] in Specimen |
31832-9 |
Giardia lamblia Ag [Presence] in Stool --3rd specimen |
31936-8 |
Pneumocystis jirovecii Ag [Presence] in Nose |
32057-2 |
Butalbital [Presence] in Specimen |
3219-3 |
Coagulation factor X activity [Units/volume] in Platelet poor plasma by Chromogenic method |
32525-8 |
CD19 cells/cells in Bone marrow |
32686-8 |
Hepatitis B virus DNA [Mass/volume] in Serum |
32996-1 |
HER2 Ag [Mass/volume] in Serum |
33317-9 |
Schistosoma sp IgG Ab [Presence] in Serum |
33562-0 |
Ampicillin [Mass/volume] in Serum or Plasma --peak |
33707-1 |
Yersinia pestis Ab [Titer] in Serum |
33946-5 |
Ziprasidone [Mass/volume] in Serum or Plasma |
34211-3 |
11-Hydroxyetiocholanolone [Moles/volume] in Urine |
34324-4 |
Lactate [Moles/volume] in Urine |
34447-3 |
Cache valley virus RNA [Presence] in Blood by NAA with probe detection |
3457-9 |
chlordiazePOXIDE [Mass/volume] in Serum or Plasma |
34701-3 |
Heparin induced platelet Ab [Presence] in Serum |
3508-9 |
Codeine [Mass/volume] in Urine |
35230-2 |
Triiodothyronine (T3) Free [Mass or Moles/volume] in Serum or Plasma |
35383-9 |
Galactomannan Ag [Units/volume] in Serum or Plasma |
35506-5 |
Chronic lymphocytic leukemia gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
3564-2 |
Dimetamphetamine [Presence] in Urine |
35875-4 |
Herpes simplex virus 1+2 Ab [Units/volume] in Cerebrospinal Fluid |
35977-8 |
XR tomography Lower extremity - left |
36080-0 |
MRA Upper extremity veins |
36185-7 |
CT Forearm W contrast IV |
36290-5 |
CT Lower extremity - left WO and W contrast IV |
36395-2 |
CT Shoulder WO and W contrast IV |
3650-9 |
fluPHENAZine [Mass/volume] in Serum or Plasma |
36605-4 |
XR Knee - bilateral Lateral |
36707-8 |
XR Humerus - bilateral AP and Lateral |
36811-8 |
CT Joint Arthrogram |
36932-2 |
CT Pituitary and Sella turcica |
37041-1 |
XR Knee - bilateral Tunnel |
37148-4 |
XR Mandible PA and Lateral and Oblique and Towne |
3726-7 |
Lormetazepam [Mass/volume] in Urine |
37429-8 |
XR tomography Wrist - bilateral |
37546-9 |
XR Temporomandibular joint - bilateral Open and Closed mouth |
37653-3 |
XR tomography Sacrum |
37756-4 |
XR Knee - right Tunnel W standing |
37860-4 |
XR Sinuses PA and Lateral and Caldwell and Waters |
37971-9 |
RFA Subclavian vein Views W contrast IV |
38090-7 |
MG Breast - bilateral Air gap Views |
38250-7 |
Calcium [Mass/volume] in Specimen |
38445-3 |
Calprotectin [Mass/mass] in Stool |
38594-8 |
Epichlorohydrin [Mass/volume] in Air |
38712-6 |
N-nitrosodimethylamine [Mass/volume] in Air |
38819-9 |
XR Hip - right Lateral during surgery |
38998-1 |
HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection |
39144-1 |
RF Gastrointestinal tract upper Single view W air contrast PO |
39377-7 |
XR Hip - right Views and Lateral crosstable |
39484-1 |
OLANZapine [Moles/volume] in Serum or Plasma |
39598-8 |
Curvularia lunata IgE Ab/IgE total in Serum |
3971-9 |
Pindolol [Mass/volume] in Serum or Plasma |
39826-3 |
NM Whole body Bone marrow Views |
39942-8 |
NM Lung Ventilation and Perfusion |
40413-7 |
Barbiturates [Presence] in Hair |
40569-6 |
Eosinophils [#/volume] in Body fluid by Manual count |
40724-7 |
Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay |
40847-6 |
Brome IgG4 Ab [Mass/volume] in Serum |
40992-0 |
Rhinovirus+Enterovirus Ag [Presence] in Specimen by Immunofluorescence |
41109-0 |
FGD1 gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal |
41270-0 |
Drugs identified in Urine |
41448-2 |
Plasmodium malariae DNA [Presence] in Blood by NAA with probe detection |
41747-7 |
Budesonide [Mass/volume] in Serum or Plasma |
41877-2 |
Bordetella pertussis IgA and IgG and IgM panel [Units/volume] - Serum by Immunoassay |
42256-8 |
Shigella boydii Ag [Presence] in Isolate |
42403-6 |
XR Lumbar spine Views AP W right bending and W left bending |
42528-0 |
Phenothiazines [Mass/volume] in Serum or Plasma |
42716-1 |
Mycobacterium sp rRNA [Identifier] in Isolate by NAA with probe detection |
42921-7 |
JC virus DNA [Presence] in Specimen by NAA with probe detection |
43041-3 |
Echovirus 9 Ab [Titer] in Body fluid |
43164-3 |
Silica [Mass/volume] in Water |
43318-5 |
Avian metapneumovirus A Ab [Presence] in Serum by Immunofluorescence |
43454-8 |
MR Pulmonary system |
43595-8 |
Methadone [Presence] in Meconium |
43725-1 |
2,4-Dichlorophenol [Presence] in Urine |
43863-0 |
Benzthiazide [Presence] in 24 hour Urine |
43977-8 |
Anabolic steroids [Presence] in Urine |
44150-1 |
NM Brain Views W Tc-99m bicisate IV |
44285-5 |
3-Methylcrotonylglycine/Creatinine [Mass Ratio] in 24 hour Urine |
44405-9 |
Sodium/Creatinine [Molar ratio] in 24 hour Urine |
44520-5 |
Herpes virus 6 IgG Ab [Presence] in Cerebrospinal Fluid |
44771-4 |
Varicella zoster virus Ab [Titer] in Serum by Immunofluorescence |
44979-3 |
Chlamydophila pneumoniae Ab [Presence] in Serum --2nd specimen |
45109-6 |
Chlamydia sp Ag [Presence] in Body fluid by Immunofluorescence |
4523-7 |
Complement iC3b receptors [Entitic number] in Leukocytes |
46084-0 |
Immunoglobulin light chains [Mass/time] in 24 hour Urine |
46276-2 |
Rh [Type] in Blood--after transfusion reaction |
46396-8 |
SPECT Heart gated at rest and W Tc-99m Sestamibi IV |
46981-7 |
Silicon [Mass/volume] in Urine |
47112-8 |
Gold [Moles/time] in 24 hour Urine |
47375-1 |
XR Knee - right 1 or 2 Views |
47514-5 |
Treponema pallidum IgM Ab [Units/volume] in Cerebrospinal Fluid |
47636-6 |
Glycine/Amino acids.total in Cerebrospinal Fluid |
47789-3 |
Threonine/Amino acids.total in DBS |
48016-0 |
Genechip kit panel - Blood or Tissue by Molecular genetics method |
48187-9 |
Chloramin T triggered leukotriene release [Mass/volume] by Leukocytes |
48300-8 |
Erythrosine triggered leukotriene release [Mass/volume] by Leukocytes |
48420-4 |
Complement C3c [Mass/volume] in Body fluid |
48587-0 |
Collagen crosslinked C-telopeptide/Creatinine [Ratio] in Urine |
48737-1 |
XR Wrist and Hand 3 Views |
48871-8 |
Rickettsia typhus group DNA [Presence] in Specimen by NAA with probe detection |
48988-0 |
Glucose [Mass/volume] in Serum or Plasma --12 PM specimen |
49144-9 |
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid |
49351-0 |
Cytomegalovirus DNA [#/volume] (viral load) in Tissue by NAA with probe detection |
49464-1 |
CD13 Ag [Presence] in Tissue by Immune stain |
49619-0 |
Indinavir+Ritonavir [Susceptibility] by Genotype method |
49739-6 |
Honey bee IgG Ab [Mass/volume] in Serum |
49884-0 |
Lymphocyte proliferation stimulated by tetanus toxoid [Ratio] in Blood --7 day post incubation |
50039-7 |
5-Methyltetrahydrofolate/Folate in Serum or Plasma |
50163-5 |
Acylcarnitine [Moles/volume] in Cerebrospinal Fluid |
50320-1 |
Helicobacter pylori Ag [Presence] in Tissue by Immune stain |
5058-3 |
Blastomyces dermatitidis Ab [Presence] in Serum by Immune diffusion (ID) |
5070-8 |
Brucella sp IgM Ab [Units/volume] in Serum |
5085-6 |
Chlamydia sp IgG Ab [Units/volume] in Serum |
50960-4 |
Rabbit Ab [Presence] in Serum |
51395-2 |
XR Ankle and Foot - left Views |
5160-7 |
Epstein Barr virus capsid IgM Ab [Titer] in Serum by Immunofluorescence |
51774-8 |
Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
51924-9 |
Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence |
5230-8 |
Influenza virus B Ab [Titer] in Serum by Complement fixation |
5290-2 |
Reagin Ab [Presence] in Cerebrospinal Fluid by VDRL |
5301-7 |
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoassay |
53142-6 |
Nitrogen [Moles/time] in 24 hour Stool |
53255-6 |
Mycoplasma pneumoniae DNA [#/volume] in Specimen by NAA with probe detection |
53459-4 |
Decadienoylcarnitine (C10:2) [Moles/volume] in Amniotic fluid |
53597-1 |
Mannobioside IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
5375-1 |
Taenia solium adult Ab [Units/volume] in Serum by Immunoassay |
53888-4 |
PHEX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
54030-2 |
Smith extractable nuclear B Ab [Presence] in Serum |
54228-2 |
Lymphoma - CLL screen panel - Specimen by Flow cytometry (FC) |
54377-7 |
Cobalamin (Vitamin B12) [Mass/volume] in Body fluid |
54927-9 |
Tetranychus urticae IgE Ab [Units/volume] in Serum |
55300-8 |
JAK2 gene exon 12 targeted mutation analysis in Blood or Tissue by Molecular genetics method |
55593-8 |
Creatinine [Moles/volume] in Urine collected for unspecified duration |
55859-3 |
Folate [Mass/volume] in Cerebrospinal Fluid |
55976-5 |
pH of Nonbiological fluid |
56199-3 |
Brewer's yeast IgG4 Ab [Mass/volume] in Serum |
5630-9 |
Copper [Mass/volume] in Red Blood Cells |
56401-3 |
Tea IgG4 Ab [Mass/volume] in Serum |
5654-9 |
Gallium [Mass/volume] in Urine |
567-8 |
Diphtheria identified in Specimen by Organism specific culture |
56919-4 |
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
5724-0 |
Selenium [Mass/volume] in Serum or Plasma |
57452-5 |
Ma+Ta Ab [Presence] in Cerebrospinal Fluid by Immunoblot |
57845-0 |
Leukocytes [#/volume] in Body fluid by Automated count |
57999-5 |
Manganese [Mass/volume] in Cerebrospinal Fluid |
58380-7 |
fentaNYL/Creatinine [Mass Ratio] in Urine |
58682-6 |
Sulfatides [Mass/volume] in Urine |
58913-5 |
Parrot feather IgG Ab [Mass/volume] in Serum |
5909-7 |
Blood smear finding [Identifier] in Blood by Light microscopy |
59294-9 |
Levamisole [Mass/mass] in Tissue |
59422-6 |
Leptospira interrogans sv Javanica Ab [Titer] in Serum by Agglutination |
59665-0 |
Estazolam [Mass/volume] in Blood by Confirmatory method |
59769-0 |
Postprocedure diagnosis Narrative |
59922-5 |
Mefenamate [Moles/volume] in Urine |
60063-5 |
buPROPion [Mass/mass] in Tissue |
60166-6 |
Platinum [Mass/mass] in Nail |
60298-7 |
cloZAPine [Moles/volume] in Specimen |
60405-8 |
Sole IgG Ab [Mass/volume] in Serum |
60578-2 |
TCRG gene rearrangements [Presence] in Body fluid by Molecular genetics method |
60863-8 |
Sevoflurane [VFr/PPres] Airway adaptor |
61040-2 |
N-desalkylflurazepam [Presence] in Urine |
6117-6 |
Red Imported Fire Ant IgE Ab [Units/volume] in Serum |
61284-6 |
Cajeput tree IgE Ab/IgE total in Serum |
61393-5 |
Human papilloma virus 6 DNA [Presence] in Specimen by NAA with probe detection |
6213-3 |
Pepper tree IgE Ab [Units/volume] in Serum |
62462-7 |
Influenza virus A+B RNA [Presence] in Specimen by NAA with probe detection |
63081-4 |
Brazil Nut IgG Ab [Mass/volume] in Serum |
63182-0 |
White Oak IgG Ab [Mass/volume] in Serum |
63284-4 |
Mitochondria M5 Ab [Presence] in Serum by Immunofluorescence |
63393-3 |
Jo-1 extractable nuclear Ab [Units/volume] in Body fluid by Immunoassay |
63540-9 |
Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid |
64137-3 |
Pregabalin [Presence] in Urine by Screen method |
64976-4 |
Cat recombinant (rFel d) 4 IgE Ab [Units/volume] in Serum |
6569-8 |
Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence |
66117-3 |
Prostate Pathology biopsy report |
66732-9 |
Corticotropin [Mass or Moles/volume] in Plasma |
67795-5 |
Vital signs, weight, height, head circumference and oximetry panel HITSP |
68411-8 |
Macrophages [#/volume] in Synovial fluid by Manual count |
6895-7 |
Butalbital [Mass/volume] in Serum or Plasma |
69107-1 |
CT Wrist - left Arthrogram |
69212-9 |
MR Pelvis limited |
69361-4 |
PCA3 score in Urine by Molecular genetics method |
69726-8 |
Tissue transglutaminase IgA + Gliadin peptides IgA and IgG panel - Serum |
69929-8 |
Respiratory syncytial virus IgA Ab [Presence] in Serum by Immunoassay |
70136-7 |
Rickettsia spotted fever group IgM Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
7062-3 |
Red Alder IgE Ab [Units/volume] in Serum |
7119-1 |
Basil IgG Ab [Units/volume] in Serum |
71768-6 |
Ebola virus Ag [Presence] in Specimen by Immunoassay |
72211-6 |
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
72378-3 |
Oxazepam [Mass/volume] in Saliva (oral fluid) |
72484-9 |
BK virus subtype in Blood by NAA with probe detection |
72631-5 |
Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method |
72779-2 |
JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine |
72907-9 |
HNA genotype panel - Serum or Plasma |
7302-3 |
Chinese Elm IgE Ab [Units/volume] in Serum |
73125-7 |
Telmisartan induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73227-1 |
Oxaliplatin induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73330-3 |
Ipratropium induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73432-7 |
cloNIDine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73536-5 |
ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC) |
73727-0 |
Methadone [Presence] in Hair |
73894-8 |
Tetrahydrocortisone [Moles/volume] in Urine |
74004-3 |
ABCB1 gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal |
7420-3 |
Horseradish IgE Ab [Units/volume] in Serum |
7438-5 |
Kapok triggered histamine release [Units/volume] in Blood |
74530-7 |
Dicarboxypalmitoleylcarnitine (C16:1-DC) [Moles/volume] in Serum or Plasma |
74666-9 |
Monoclonal band observed [Identifier] in Urine by Immunofixation |
74844-2 |
Baylisascaris sp IgG Ab [Presence] in Serum by Immunoassay |
74978-8 |
Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/mass] - Leukocytes |
75089-3 |
5-Oxoproline [Moles/volume] in Serum or Plasma |
75242-8 |
Antipsychotics [Presence] in Urine by Screen method |
75515-7 |
Lupus anticoagulant aPTT and dRVVT screening panel W Reflex |
75661-9 |
Granulocytes [#] in Pleural fluid by Manual count |
75866-4 |
HEDIS 2015-2018 Value Set - PSA Tests |
76017-3 |
Halothane liquid delivered.total [Volume] in Reporting period from Gas delivery system |
76132-0 |
Sucrose/Creatinine [Molar ratio] in Urine |
76470-4 |
Organization federal tax ID |
76674-1 |
Leukocytes [#/volume] in Cerebrospinal Fluid --1st tube |
77067-7 |
SEPT9 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
77176-6 |
Hepatitis B virus little e Ag and Ab panel - Serum |
77385-3 |
Parainfluenza virus 1 Ag [Presence] in Bronchoalveolar lavage by Immunofluorescence |
7768-5 |
Yellow Jacket IgG Ab [Units/volume] in Serum |
7817-0 |
Borrelia burgdorferi IgG Ab [Units/volume] in Serum |
7858-4 |
Dengue virus 4 Ab [Presence] in Serum by Immunoassay |
78851-3 |
M-chlorophenylpiperazine [Mass/mass] in Hair |
79091-5 |
CT Thoracic spine by reconstruction WO contrast |
79222-6 |
Benzodiazepines [Presence] in Body fluid by Screen method |
79366-1 |
XR Ribs - unilateral and Chest 2 Views |
79504-7 |
Levulinate/Creatinine [Molar ratio] in Urine |
79898-3 |
Objective refraction panel |
80195-1 |
Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method |
8048-1 |
Varicella zoster virus IgM Ab [Units/volume] in Serum |
80637-2 |
Bedaquiline [Mass/volume] in Serum or Plasma |
80863-4 |
US.doppler for transplanted kidney |
81111-7 |
Murray Valley encephalitis virus IgG Ab [Presence] in Serum |
81390-7 |
Left ventricular Cardiac output by US 3D |
81596-9 |
NM Lung Quantitative Views Ventilation and Perfusion |
81772-6 |
European house dust mite IgG Ab [Mass/volume] in Serum |
81874-0 |
SLC12A3 gene full mutation analysis in Blood or Tissue by Sequencing |
82172-8 |
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
82298-1 |
Yersinia enterocolitica [Presence] in Specimen by Culture |
82476-3 |
Borrelia miyamotoi glpQ gene [Presence] in Cerebrospinal Fluid by NAA with non-probe detection |
82696-6 |
CT Spine Lumbar and Sacrum W contrast IV |
82889-7 |
Meta methylhippurate+Ortho methylhippurate+Para methylhippurate [Moles/volume] in Urine |
83028-1 |
XR Cervical and thoracic and lumbar spine GE 2 Views |
83293-1 |
CT Spine Cervical and Spine Lumbar W contrast IV |
85362-2 |
Mycobacterium tuberculosis complex DNA [Presence] in Sputum or Bronchial by NAA with probe detection |
85778-9 |
Haemophilus influenzae DNA [Presence] by NAA with non-probe detection in Positive blood culture |
86030-4 |
Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
86142-7 |
Streptococcus pneumoniae Danish serotype 7A IgG Ab [Units/volume] in Serum by Immunoassay |
86363-9 |
MG Guidance for additional vacuum biopsy of Breast - left |
86536-0 |
Hantavirus RNA [Presence] in Cerebrospinal Fluid by NAA with probe detection |
86859-6 |
Dengue virus 3 neutralizing antibody [Titer] in Specimen by Neutralization test |
87033-7 |
Guidance for drainage and placement of chest tube of Pleural space |
87146-7 |
Guidance for injection of Shoulder |
87363-8 |
Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control in Serum by Immunoassay |
87552-6 |
IgA, IgA1 and IgA2 panel - Serum or Plasma |
87669-8 |
Chlorinated hydrocarbon panel - Specimen |
87818-1 |
Tapentadol [Presence] in Saliva (oral fluid) by Screen method |
87934-6 |
Bacteria identified in Bile fluid by Anaerobe culture |
88054-2 |
Lipopolysaccharide binding protein [Mass/volume] in Serum or Plasma by Immunoassay |
88218-3 |
Parechovirus RNA [Presence] in Stool by NAA with probe detection |
88454-4 |
Mumps virus IgG+IgM Ab [Interpretation] in Cerebrospinal Fluid Qualitative by Immunofluorescence |
88632-5 |
Microscopic observation [Identifier] in Lower respiratory specimen by Gram stain |
88894-1 |
Brivaracetam [Mass/volume] in Serum or Plasma |
89271-1 |
Heart rate --during apnea |
89527-6 |
Sjogrens syndrome-A extractable nuclear Ab [Presence] in Cerebrospinal Fluid by Line blot |
89708-2 |
CT Guidance for injection of Knee - left |
90042-3 |
Borrelia sp DNA [Presence] in Tick by NAA with probe detection |
90320-3 |
Aichivirus C RNA [#/volume] (viral load) in Specimen by NAA with probe detection |
90779-0 |
Adalimumab Ab [Units/volume] in Serum by Immunoassay |
91033-1 |
Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method |
91670-0 |
Orexin-A [Mass/volume] in Cerebrospinal Fluid |
91850-8 |
Microscopic observation [Identifier] in Genital specimen by Giemsa stain |
92502-4 |
Hemoglobin S inferred phenotype [Presence] in Blood or Tissue by Molecular genetics method |
92707-9 |
Care team information panel |
92924-0 |
CT Guidance for aspiration of Abdomen |
9332-8 |
Carbon tetrachloride [Mass/volume] in Blood |
93506-4 |
Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine |
93795-3 |
NOP56 gene GGCCTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
93972-8 |
Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma |
94217-7 |
TP53 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
94353-0 |
Myelopathy autoimmune Ab panel - Cerebrospinal Fluid |
94565-9 |
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection |
94720-0 |
SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
95119-4 |
Insulin [Units/volume] in Serum or Plasma --4 hours post meal |
95285-3 |
RAB7A gene full mutation analysis in Blood or Tissue by Sequencing |
95655-7 |
Western equine encephalitis virus neutralizing antibody [Titer] in Specimen by Neutralization test |
9581-0 |
Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
96258-9 |
Cholesterol in LDL [Moles/volume] in Serum or Plasma by Calculated by Martin-Hopkins |
96449-4 |
Cell growth [Presence] of Tumor in Tissue culture |
96594-7 |
Glucose [Mass/volume] in DBS |
96815-6 |
Piper gurnard IgE Ab [Units/volume] in Serum |
97161-4 |
Amphetamines panel - Urine by Confirmatory method |
97280-2 |
Morphine Free [Presence] in Cord tissue by Screen method |
97402-2 |
XR Finger fourth - right AP and Lateral |
97515-1 |
Entamoeba bangladeshi DNA [Presence] in Specimen by NAA with probe detection |
97762-9 |
Parathyrin.intact [Moles/volume] in Body fluid |
97985-6 |
Honey bee phospholipase A2 recombinant (rApi m) 1 IgG4 Ab [Mass/volume] in Serum |
9813-7 |
Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen |
98315-5 |
XR Calcaneus - bilateral Lateral |
98900-4 |
XR Wrist - left Pronated oblique |
99153-9 |
Outcome and assessment information set (OASIS) form - version E - Follow Up during assessment period [CMS Assessment] |
99455-8 |
Amoxicillin IgG Ab [Mass/volume] in Serum |
End of sample. 500 of 56,840 codes are listed above; $expand the set against the terminology service for all of them.